Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression. [electronic resource]
Producer: 20080320Description: 130-4 p. digitalISSN:- 0026-2862
- Angiogenesis Inhibitors -- pharmacology
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Cells, Cultured
- DNA Replication -- drug effects
- Diabetic Retinopathy -- metabolism
- Down-Regulation
- Endothelial Cells -- drug effects
- Glycation End Products, Advanced -- metabolism
- Humans
- Imidazoles -- pharmacology
- NF-kappa B -- genetics
- Neovascularization, Pathologic -- genetics
- Promoter Regions, Genetic
- RNA, Messenger -- metabolism
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic -- genetics
- Research Design
- Tetrazoles -- pharmacology
- Transfection
- Vascular Endothelial Growth Factor A -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.